159 related articles for article (PubMed ID: 34008082)
1. A Systematic Approach in the Development of the Morphologically-Directed Raman Spectroscopy Methodology for Characterizing Nasal Suspension Drug Products.
Farias G; Shur J; Price R; Bielski E; Newman B
AAPS J; 2021 May; 23(4):73. PubMed ID: 34008082
[TBL] [Abstract][Full Text] [Related]
2. Scientific Considerations for the Review and Approval of First Generic Mometasone Furoate Nasal Suspension Spray in the United States from the Bioequivalence Perspective.
Liu Q; Absar M; Saluja B; Guo C; Chowdhury B; Lionberger R; Conner DP; Li BV
AAPS J; 2019 Jan; 21(2):14. PubMed ID: 30617594
[TBL] [Abstract][Full Text] [Related]
3. Sensitivity of Pharmacokinetics to Differences in the Particle Size Distribution for Formulations of Locally Acting Mometasone Furoate Suspension-Based Nasal Sprays.
Amini E; Berger SM; Schilling U; Jiao Y; Chen MJ; Bachhav S; Baumstein SM; Tang Y; Al-Humiari M; Leon Astudillo CE; Drescher S; Iley T; Shur J; Price R; Carrasco C; Conti DS; Delvadia R; Oguntimein O; Witzmann K; Absar M; Luke MC; Boc S; Dhapare S; Saluja B; Bielski E; Newman B; Bulitta JB; Hochhaus G
Mol Pharm; 2023 Nov; 20(11):5690-5700. PubMed ID: 37773975
[TBL] [Abstract][Full Text] [Related]
4. Analytical method development for characterizing ingredient-specific particle size distributions of nasal spray suspension products.
Thomas BJ; Absar M; Delvadia R; Conti DS; Witzmann K; Guo C
J Pharm Sci; 2021 Jul; 110(7):2778-2788. PubMed ID: 33713688
[TBL] [Abstract][Full Text] [Related]
5. Raman chemical imaging for ingredient-specific particle size characterization of aqueous suspension nasal spray formulations: a progress report.
Doub WH; Adams WP; Spencer JA; Buhse LF; Nelson MP; Treado PJ
Pharm Res; 2007 May; 24(5):934-45. PubMed ID: 17372686
[TBL] [Abstract][Full Text] [Related]
6. Absorption and Clearance of Pharmaceutical Aerosols in the Human Nose: Effects of Nasal Spray Suspension Particle Size and Properties.
Rygg A; Hindle M; Longest PW
Pharm Res; 2016 Apr; 33(4):909-21. PubMed ID: 26689412
[TBL] [Abstract][Full Text] [Related]
7. First Approval of Generic Mometasone Furoate Nasal Suspension Spray in Japan: Similarities and Differences Between Japan and the USA.
Kuribayashi R; Kasuga M; Kuwana K; Yamaguchi T
Ther Innov Regul Sci; 2023 Mar; 57(2):173-177. PubMed ID: 36100793
[TBL] [Abstract][Full Text] [Related]
8. Effects of a Thermosensitive In Situ Gel Containing Mometasone Furoate on a Rat Allergic Rhinitis Model.
Altuntaş E; Yener G; Doğan R; Aksoy F; Şerif Aydın M; Karataş E
Am J Rhinol Allergy; 2018 May; 32(3):132-138. PubMed ID: 29644886
[TBL] [Abstract][Full Text] [Related]
9. Analyzing ophthalmic suspension particle size distributions using laser diffraction: Placebo background subtraction method.
Vo A; Feng X; Smith WC; Zhu D; Patel M; Kozak D; Wang Y; Zheng J; Ashraf M; Xu X
Int J Pharm; 2021 Apr; 598():120401. PubMed ID: 33636327
[TBL] [Abstract][Full Text] [Related]
10. The influence of actuation parameters on in vitro testing of nasal spray products.
Guo C; Doub WH
J Pharm Sci; 2006 Sep; 95(9):2029-40. PubMed ID: 16865693
[TBL] [Abstract][Full Text] [Related]
11. Formulation of a novel fixed dose combination of salmeterol xinafoate and mometasone furoate for inhaled drug delivery.
Liu S; Watts AB; Du J; Bui A; Hengsawas S; Peters JI; Williams RO
Eur J Pharm Biopharm; 2015 Oct; 96():132-42. PubMed ID: 26220015
[TBL] [Abstract][Full Text] [Related]
12. Analytical Challenges of Spray Pattern Method Development for Purposes of
Grmaš J; Dreu R; Injac R
J Aerosol Med Pulm Drug Deliv; 2019 Aug; 32(4):200-212. PubMed ID: 30964389
[No Abstract] [Full Text] [Related]
13. Comparison of mometasone furoate monohydrate (Nasonex) and fluticasone propionate (Flixonase) nasal sprays in the treatment of dust mite-sensitive children with perennial allergic rhinitis.
Mak KK; Ku MS; Lu KH; Sun HL; Lue KH
Pediatr Neonatol; 2013 Aug; 54(4):239-45. PubMed ID: 23597528
[TBL] [Abstract][Full Text] [Related]
14. The surface characterisation and comparison of two potential sub-micron, sugar bulking excipients for use in low-dose, suspension formulations in metered dose inhalers.
James J; Crean B; Davies M; Toon R; Jinks P; Roberts CJ
Int J Pharm; 2008 Sep; 361(1-2):209-21. PubMed ID: 18577435
[TBL] [Abstract][Full Text] [Related]
15. A new approach in the prediction of the dissolution behavior of suspended particles by means of their particle size distribution.
Tinke AP; Vanhoutte K; De Maesschalck R; Verheyen S; De Winter H
J Pharm Biomed Anal; 2005 Oct; 39(5):900-7. PubMed ID: 16023816
[TBL] [Abstract][Full Text] [Related]
16. In vitro physicochemical characterization and dissolution of brinzolamide ophthalmic suspensions with similar composition.
Vo A; Feng X; Patel D; Mohammad A; Patel M; Zheng J; Kozak D; Choi S; Ashraf M; Xu X
Int J Pharm; 2020 Oct; 588():119761. PubMed ID: 32795488
[TBL] [Abstract][Full Text] [Related]
17. Nasal Deposition of HFA-Beclomethasone, Aqueous Fluticasone Propionate and Aqueous Mometasone Furoate in Allergic Rhinitis Patients.
Leach CL; Kuehl PJ; Chand R; McDonald JD
J Aerosol Med Pulm Drug Deliv; 2015 Oct; 28(5):334-40. PubMed ID: 25671692
[TBL] [Abstract][Full Text] [Related]
18. Laboratory Performance Testing of Aqueous Nasal Inhalation Products for Droplet/Particle Size Distribution: an Assessment from the International Pharmaceutical Aerosol Consortium on Regulation and Science (IPAC-RS).
Doub WH; Suman JM; Copley M; Goodey AP; Hosseini S; Mitchell JP
AAPS PharmSciTech; 2023 Oct; 24(7):208. PubMed ID: 37817001
[TBL] [Abstract][Full Text] [Related]
19. Influence of the size of micronized active pharmaceutical ingredient on the aerodynamic particle size and stability of a metered dose inhaler.
Berry J; Kline LC; Sherwood JK; Chaudhry S; Obenauer-Kutner L; Hart JL; Sequeira J
Drug Dev Ind Pharm; 2004 Aug; 30(7):705-14. PubMed ID: 15491048
[TBL] [Abstract][Full Text] [Related]
20. Topologically directed confocal Raman imaging (TD-CRI): Advanced Raman imaging towards compositional and micromeritic profiling of a commercial tablet components.
Muthudoss P; Kumar S; Ann EYC; Young KJ; Chi RLR; Allada R; Jayagopal B; Dubala A; Babla IB; Das S; Mhetre S; Saraf I; Paudel A
J Pharm Biomed Anal; 2022 Feb; 210():114581. PubMed ID: 35026592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
